EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Mitogen signaling strength and duration can control cell cycle decisions

Ruth Nussinov iD, Wengang Zhang iD, Yonglan Liu iD, Hyunbum Jang iD

Science Advances · 05.07.2024 · 10 (27)

DOI: 10.1126/sciadv.adm9211 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Science Advances, erschienen am 05.07.2024. Verfasst von Ruth Nussinov und 3 weiteren Autor:innen. Beteiligte Einrichtung: Computational Structural Biology Section, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA. Hauptthemen laut MEDLINE: Signal Transduction, Cell Cycle, Cell Differentiation. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Decades ago, mitogen-promoted signaling duration and strength were observed to be sensed by the cell and to be critical for its decisions: to proliferate or differentiate. Landmark publications established the importance of mitogen signaling not only in the G 1 cell cycle phase but also through the S and the G 2 /M transition. Despite these early milestones, how mitogen signal duration and strength, short and strong or weaker and sustained, control cell fate has been largely unheeded. Here, we center on cardinal signaling-related questions, including (i) how fluctuating mitogenic signals are converted into cell proliferation-differentiation decisions and (ii) why extended duration of weak signaling is associated with differentiation, while bursts of strong and short induce proliferation but, if too strong and long, induce irreversible senescence. Our innovative broad outlook harnesses cell biology and protein conformational ensembles, helping us to define signaling strength, clarify cell cycle decisions, and thus cell fate.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Signal TransductionCell CycleCell DifferentiationHumansAnimalsMitogensCell Proliferation

Substanzen

Mitogens

Autor:innen und Institutionen

  • Computational Structural Biology Section, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
  • Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
  • Cancer Innovation Laboratory, National Cancer Institute, Frederick, MD 21702, USA.

ORCID-Profile: Ruth Nussinov, Wengang Zhang, Yonglan Liu, Hyunbum Jang

Förderung

  • NCI NIH HHS

Zitieren

APA

Nussinov, R., Zhang, W., Liu, Y., & Jang, H. (2024). Mitogen signaling strength and duration can control cell cycle decisions. Science Advances, 10(27). https://doi.org/10.1126/sciadv.adm9211

Vancouver

Nussinov R, Zhang W, Liu Y, Jang H. Mitogen signaling strength and duration can control cell cycle decisions. Science Advances. 2024;10(27). doi:10.1126/sciadv.adm9211

BibTeX
@article{Nussinov2024,
  author = {Nussinov, Ruth and Zhang, Wengang and Liu, Yonglan and Jang, Hyunbum},
  title = {Mitogen signaling strength and duration can control cell cycle decisions},
  journal = {Science Advances},
  year = {2024},
  volume = {10},
  number = {27},
  doi = {10.1126/sciadv.adm9211}
}
Kostenlos starten →